Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials

The epidermal growth factor receptor (EGFR) family contains four transmembrane tyrosine kinases (EGFR1/ErbB1, Her2/ErbB2, Her3/ErbB3 and Her4/ErbB4) and 13 secreted polypeptide ligands. EGFRs are overexpressed in many solid tumors, including breast, pancreas, head-and-neck, prostate, ovarian, renal,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancers (Basel)
Autori principali: Maennling, Amaia Eleonora, Tur, Mehmet Kemal, Niebert, Marcus, Klockenbring, Torsten, Zeppernick, Felix, Gattenlöhner, Stefan, Meinhold-Heerlein, Ivo, Hussain, Ahmad Fawzi
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6966464/
https://ncbi.nlm.nih.gov/pubmed/31756933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11121826
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi